Stockreport

Lumos Pharma Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]

Lumos Pharma, Inc.  (LUMO) 
PDF US$4.18 loss per share (further deteriorated from US$3.71 loss in FY 2022). All figures shown in the chart above are for the trailing 12 month (TTM) period Lumos Ph [Read more]